Emergent Biosolutions Inc (EBS) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NYSE. Price $6.80 (-3.13%), Market cap $0.44B, 52-week low–high $5.63 ~ $13.90.
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botulism Antitoxin Heptavalent (BAT), an equine plasma antitoxin for the treatment of symptomatic botulism; BioThrax, an anthrax vaccine; CYFENDUS, a vaccine for post-exposure prophylaxis of disease follow
Financial statements, price targets, institutional (13F) holdings and related news for Emergent Biosolutions Inc are updated in real time on BlackAll Trade.
Emergent Biosolutions Inc trades at $6.80 (-3.13%). Real-time quotes and charts are available on BlackAll Trade.
Emergent Biosolutions Inc has a market cap of about $0.44B.
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada